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Faculty of Pharmaceutical Sciences, University of Tokyo, Hongo, Bunkyo-ku, Tokyo, Japan Summary: Tr acer distribution kinetics in the determina tion of local cerebral blood flow (LCBF) were examined by using three models, i.e., venous equilibrium, tube, and distributed models. The technique most commonly used for measuring LCBF is the tissue uptake method, which was first developed and applied by Kety (1951) . The mea surement of LCBF with the 1 4C-iodoantipyrine (lAP) method is calculated by using an equation derived by Kety based on the Fick's principle and a two-compart ment model of blood-tissue exchange and tissue concen tration at a single data point (Sakurada et aI. , 1978) . The procedure, in which the tissue is to be in equilibrium with venous blood, will be referred to as the tissue equilibra tion model. In this article, effects of the concentration gradient of tracer along the length of the capillary (tube model) and the transverse heterogeneity in the capillary transit time (distributed model) on the determination of LCBF were theoretically analyzed for the tissue sampling method. Similarities and differences among these models There are two methods for measuring local cere bral blood flow (LCBF), i.e., the tissue uptake and the tissue washout or clearance methods. Of these two methods, the one most commonly used in an imal studies is the tissue uptake method. This method was first developed and applied by Kety (1951) . In this method, a highly diffusible radioac tive substance [for example, 14 C-iodoantipyrine (lAP)] at the blood-brain barrier (BBB) is intrave nously administered, blood is continuously sam pled, samples of brain at the last sampling time are obtained, and the radioactivities of the indicator in are explored. The rank order of the LCBF calculated by using arterial blood concentration time courses and the tissue concentration of tracer based on each model were tube model (model II) < distributed model (model III) < venous equilibrium model (model I). Data on 1 4C-IAP ki netics reported by Ohno et al. (1979) were employed. The
LCBFs calculated based on model I were 45-260% larger than those in models II or III. To discriminate among three models, we propose to examine the effect of al tering the venous infusion time of tracer on the apparent tissue-to-blood concentration ratio (Aapp). A range of the ratio of the predicted Aapp in models II or III to that in model I was from 0.6 to 1.3. In the future, there may be a need to determine which model should be used to calcu late the LCBF based on this discriminator and to develop another discriminator by using multiple data points based on positron emission tomography. Key Words: Capillary transit time-Cerebral blood flow-Distributed model -Tu be model-Venous equilibrium model. all blood and brain samples are measured. Then, the blood flow is calculated using an equation de rived by Kety (1951) and based on Fick's principle and the venous equilibrium model of the blood brain exchange. Kety et ai. (Landau et aI., 1955; Freygang and Sokoloff, 1958; Sakurada et aI., 1978) originally employed a version of the experimental procedure (quantitative autoradiographic method) and Kety's equation to estimate cerebral blood flow. It is known as the tissue saturation (Lacombe et aI., 1980) or the tissue equilibration technique. Furthermore, there have been recent developments in positron emission tomography, imaging the quantitative measurement of LCBF based on the tissue concentration time profile and the precise implementation of the dynamic tracer model (Raichle et aI., 1983) . Assumptions of these analyt ical procedures are that the brain is a single well-stirred compartment and that distribution equilib rium is achieved so rapidly that the tracer in the emergent venous blood is in equilibrium with that in the brain. Assuming passive diffusion, it then follows that the concentrations of unbound drug in the venous blood and that in the brain are equal. The tissue equilibration technique has been used by many investigators since its introduction by Kety. On the other hand, Morales and Smith (1948) , Schmidt (1953) , and Johanson and Wilson (1966) have shown that a complete description of ex change between capillary blood and tissue requires the use of a partial differential equation. Estimation of LCBF based on this analytical method and a comparison between the venous equilibrium model and the capillary perfusion model (tube model) have not yet been done. Recently, Hertz and Paulson (1980) showed that the extraction ratio of glucose increased with time in the BBB perme ability studies using the multiple indicator dilution method. This increasing extraction can be due to the heterogeneity of the cerebral circulation; the higher extraction corresponds to the longer contact with BBB and indicates a longer transit time. How ever, there is no report concerning the estimation of LCBF based on the distributed model by intro ducing the statistical distribution of the transit time among microcapillaries in the brain.
In this article, we present the tube model and the distributed model based on the concept of trans verse heterogeneity in the capillary transit time. The purpose of the present article is to derive the equations for these models and the venous equilib rium model (well-stirred model) that relate the de terminations of LCBF and to elucidate the similar ities and differences in the behavior of these models.
THEORETICAL
LCBF can be determined in experimental animals by employing the chemically inert diffusible tracer and ap plying the mathematical principles of Kety to analyze the blood-brain exchange (Kety, 1951 (Kety, , 1960 Freygang and Sokoloff, 1958; Sakurada et aI. , 1978) . Sakurada et al. (1978) showed that lAP, which has a higher oil/water par tition coefficient than antipyrine and also is more diffu sible in the cerebrovasculature, provides values of LCBF with the Kety method in the conscious rat that are com parable to those obtained using 1 3 I 1-trifluoriodmethane. The experimental design in rats based on the lAP method by Ohno et al. (I979) was as follows. The femoral vein was infused for 45 s with isotonic saline containing 9 J.LCi/ ml of lAP. Periodically during the infusion, samples of arterial blood were collected through a femoral arterial cannula. Animals were decapitated 45 s after infusion started. The skull was opened, and the brain was re moved. The blood concentration ( Cbl ood, dpm/ml) time Vol, 7, No. 4, 1987 curve and the local brain concentration of tracer were determined. The arterial blood concentration that was measured during i. v. infusion of lAP was plotted against time and was fitted by nonlinear least squares method, according to the following equation.
Cbl ood = A + Be-R t + D e-St
(1) where A, B, D, R, and S are the constants and A + B + D = 0 at t = 0 (time when the blood concentration starts to rise). Ohno et al. (1979) obtained the following result.
Cbl ood = 13,630 + 14,925 e-o . 227t -28,555 e -O. 1 2 1t (2) where 0 � t � 37 s.
The apparent tissue-to-blood concentration ratio Aapp is defined by the following equation.
(3) where CTi ss and Cbl ood are the brain parenchyma (ex cluding intravascular concentration) and the arterial blood concentration of tracer at time (n after decapita tion of animals. We used the following assumptions, which are common to the models: (1) there is no drug metabolism and excretion in the brain; (2) the binding in blood and the brain parenchyma is linear; and (3) there is no diffusional barrier between the tracer in blood and that in the brain parenchyma.
Venous equilibrium model (model I)
Assumptions of model I, illustrated in Fig. lA are: (1) each brain region is a single homogeneous compartment, and (2) the tracer in the blood leaving the brain is in equi librium with that in the brain parenchyma. The change of the tracer amount in each region is given by the following mass-balance equation. The tracer concentra tion in the brain and capillary blood is homogeneous and is also equal to that in the emergent venous blood. (8) The tube model and distributed model (models II and III). There is no mixing in the brain and capillary blood along the tube in the direction of blood flow, and tracer concentration is de creasing along the tube, as shown in the profile. Model III considers the transverse heterogeneity in the capillary blood flow (f1' f2' ... , fn)' ECF and F are the extracellular fluid compartment and total brain blood flow, respectively. tissue-to-blood concentration ratio of tracer at steady state, respectively. The solution of this equation is: (5) where CTi ss (T) equals the tissue concentration of the tracer at a given time, T, after the introduction of the tracer into the circulation. The constant K is defined as follows (Kety, 1951) .
In Eq. 6, FIW is the rate of blood flow per unit mass of tissue, and m is a constant between 0 and I that repre sents the extent to which diffusional equilibrium between blood and tissue is achieved by the marker material during its passage from the arterial to the venous end of the capillary. Based on the work of Sakurada et al. (1978) , m was taken to be equal to 1.0, and 'A was taken to be equal to 0.8 for lAP in the normal brain. Substituting Eq. I into Eq. 5 yields,
'Aa pp
where 'Aapp is the apparent tissue-to-blood concentration ratio at time T.
Tube model (model II)
Assumptions of model II, illustrated in Fig. IB are: (1) the local brain region is composed of a large number of identical tubes, arranged in parallel;
(2) blood flows uni directionally along the tubes;
(3) blood flows are the same among capillaries (ftu b e = II = fz ... = In); (4) there is no gradient in the tracer concentration from the center to surface within the cylindrical tubes; and (5) at any point along the cylinders, binding equilibrium exists between the tracer at the binding site and that in the cylindrical tube.
The release of the tracer from a brain region that might be caused by the blood flow occurs gradually along the cylinder in this nonhomogeneous model. In order to rep resent the mass balance in this model, we should con sider one segment of cylinder of the brain region. Then, if the brain region is composed of M such cylinders, which have the capillary volume of VuIM, the blood flow rate in the cylinder, it ube, and the brain parenchyma volume per cylinder, W tub e, are defined as FIM and WIM, respec tively.
Based on these assumptions, the mass-balance equa tion of the tracer amount in a cylinder is given by OCTi ss(X,t) Vu OCbl ood(X,t) Wt ube . ot =i t ube ' M . ox (9) where CT i ss(X,t) and Cbl ood(X,t) are the tracer concentra tions in the cylinder and the tracer concentration in the blood at point x (the cumulative capillary volume) and time t, respectively. As 'A is the tissue-to-blood concen tration ratio at steady state, we can obtain the following relation.
CTi s.(X,t) = 'A . Cbl ood(X,t) Substituting Eq. 10 into Eq. 9:
(12) ot oX where K = j;u b e/ 'AIW tub e = FI'AIW and X (dimensionless capillary volume) = xl(Vulm). The boundary condition is Cbl oOd(O,t) = Cbl ood(t) The solution for Cb l ood(X,t ) is as follows.
where u(y) is a step function, i.e., u(y) = 1 at y > 0, u(y) = 0 at y < 0, and u(y) = 0.5 at y = O. The averaged brain tissue concentration [C\i ss(t)] from inlet to outlet is con structed by integration from 0 to 1 as follows.
CTi ss(t)
At time T of the brain sampling, if T � II K, C\i ss (T) and 'Aapp/'A are expressed by the following equations, respec tively. and 'Aapp 
Distributed model (model III)
Assumption of model III, illustrated in Fig. IB , is as follows. The brain capillary array comprises many iden tical units whose brain cells all operate with the same tissue binding of tracers, but the fraction of cerebral blood flow assigned to individual capillaries has been given a normal distribution to late simulate the shape of indicator dilution curves (Forker and Luxon, 1978) . As a distribution of capillary flows, we used an arbitrary prob ability function. Consider N identical capillaries with a mean flow per capillary of] and a range of flows between o and 2 J Grouping the capillaries into equally spaced flow classes (n), we define fi = class midpoint = (2 . i -1). fln class width = 2 . fin (20) The fraction (Xi of capillaries in the i-th class is calculated from the normal density function as approximately the prediction of midpoint frequency and class width. Thus,
where (J is the standard deviation. To ensure that the ap proximate integration represented by Eq. 21 is consistent with the requirement that 2:�(Xi = 1, each approximation of (Xi is divided by the sum of the approximations. With this refinement and on defining the coefficient of varia tion as C = (JI], we have
2 n . C After dividing this range into 20 equally spaced flow classes, the fraction of capillaries with a particular flow was calculated from the normal density function using a coefficient of variation equal to 0.1, 0.3, 0.5, 0.7, and 0.9, respectively. In our experience, taking n = 20 will define the distribution of blood flows with sufficient precision to estimate LCBF. The fraction of total flow associated with the i-th class of capillaries is The distribution scheme is independent of the total number of capillaries. Model II is a special case of model III (n = 1).
The mass-balance equation of the tracer amount in an i-th cylinder is given by and Vu OCbl ood,i(x,t) W 3CTi ss,i(x,t) (25)
where Vu is the total volume of M capillaries, x is the cumulative volume of each capillary, X is the dimension less cumulative volume of each capillary and is the tissue-to-blood concentration ratio.
Substituting Eqs. 26 and 27 into Eq. 25 yields OCTi ss,i(X,t) = _ K . OCbl ood,i(X,t) (28)
3X
ot The averaged brain tissue concentration ( CTi ss,i(x,t)) from inlet to outlet at single capillary integration from 0 to I as follows. )
Indicator dilution method In model III, the coefficient of variation (CV) in the normal density function (Eq. 22) has to be determined. Lucignani et aL (1985) showed the concentration of vas cular reference substance in cerebral venous blood as a function of time normalized to the relative concentrations of the tracers injected into the carotid artery. We carried out the pharmacokinetic analysis for the indicator dilu tion curves and determined the CV for Eq. 22. where Do , V i nj, and F are the dose of the tracer, the injec tion volume (ml/g brain), and the total cerebral blood flow (mllmin/g brain), respectively.
Mass
The time course of the output concentration ( Cout ) frac tion of the vascular reference substance can be expressed as follows.
.u ( t -�)} 
where M . J;lF = (2 . i -l)/n and Co u/Do is the outflow fraction (ml-I ). The outflow fraction (Cou/Do ) was calcu lated from Eq. 39 using V i lli ' Vu, and F equal to 0.038 ml/g brain (Lucignani et aI., 1985) , 0.057 ml/g brain (Cremer and Seville, 1983) , and 0.8-2.5 ml/min/g brain, respec tively.
A case of linear increasing in arterial blood concentration of tracer
Simulation experiments for the estimation of the blood flow in the case of linear increase of the arterial blood concentration of tracer were carried out (Blasberg et aI. ,
1984).
Cbl ood = a . t (40) where a is a slope of the blood concentration time course .
The tissue concentration of tracer (CTis,) and Aapp/A values at time T in three models can be expressed as follows: In model I: 
Effect of coefficient of variation (CV) on estimation of K value in the distributed model (model III) Figure 2 illustrates the relationship between the CV values and a fraction of the m capillaries to each flow class (U i ) calculated from Eq. 22. When the CV value is large, the pattern of (Xi is gently sloping. However, the concentration of the density at the midarea of the flow class number is caused by small CV value. Figure 3 illustrates the relation ship between the Aa p /A. and the K value, with CV value ranging from 0.3 to 0.9 calculated from Eqs. Relationship between A.a pp A. and the K values at various infusion times of tracer and comparison among three models Figure 4 shows effects of the cerebral blood flow and the CV value in normal probability density function on indicator dilution curves of vascular reference substance based on the intracarotid injec tion method of the blood containing the tracer. As the whole brain blood flow (F, ml/min/g brain), which is required for calculation of indicator dilur-; 18 a) 0.80 ml/min/g brain 18 b) 1.50 m1/min/g brain 18 c) 2.50 m1/min/g brain tion profile in vivo, is not reported by Lucignani et al. (1985) , it is difficult to determine the reasonable CV value from comparison between the observed indicator dilution profile by Lucignani et al. (1985) and the calculated dilution profiles in Fig. 4 of this study. Accordingly, we accepted 0.3 as the CV value, jUdging from the dilution curves in the average value of LCBF (1.0-1.5 mllmin/g brain). Figure 5 illustrates the relationships between the Aapp/A and the K values at various infusion times of the tracer calculated by using Eqs. 8, 17, 19, 33, and 35 Comparison among three models in the case of linear increasing in arterial blood concentration of tracer As shown in Fig. 7 , the simulation curve in model I (Eq. 42) was larger than that in model II (Eqs. 44 and 46) at both [decapitation times T (1.0 and 0.5 min).] Furthermore, the simulation curve based on model III (Eqs. 48 and 50) lay midway between those of model I and model II. Practical examples of estimated LCBF based on three models
We compared the K values calculated from models I, II, and III using data of lAP by Ohno et al. (1979) . The method for calculation based on these models was as follows. The A, A, B, D, Rand S, and FIW (=K . A) values calculated with Eq. 7 and based on model I were conversely substituted into Eq. 8 and the observed values by Ohno et al. (1979) , and the AappA values were recalculated and presumed. Then, substituting the estimated AappA into Eqs. 17, 19, 33, and 35 based on models II and III, we can obtain the K (FIW . A) values in models II and III. As the K value is a part of multiexponen tial terms in Eqs. 17 and 33, the calculations by these equations were carried out by the Newton Raphson method. As shown in Ta ble 1, the values calculated based on model I were 45% (hippo campus) to 95% (gray matter, parietal) larger than those in model II. Furthermore, the K values in model III were 0-10% larger than those in mod el II. 
DISCUSSION
Physiologically, model II and model III appear to be more appropriate than model I to estimate LCBF. One can easily conceive of a declining tracer concentration along the length of the capil laries with distribution of tracer by brain paren chyma lining the capillaries. This plug flow situa tion is analogous to a steady-state plug flow reactor (Levenspiel, 1972) in which the material balance for a reaction component must be made for a differen tial element of volume or flow. This flow within the reactor is orderly, however, with no mixing occur ring between any element ahead of and after it. There may be lateral mixing, but no mixing or no diffusion along the paths. This pattern of circula tion may be applied to most organs within the body. Furthermore, the potential influences of the trans verse heterogeneity of the capillary transit time on elimination from the liver (Gore sky et aI., 1973; Wolkoff et aI., 1979; Sawada et aI., 1985a) , lung (Goresky et aI., 1969) , heart (Rose and Goresky, (1976», and kidney (Trainor and Silverman, 1982; Itoh et aI., 1985; Sawada et aI., 1985b) were evalu ated by using the distributed models. For example, Goresky et al. (1973) carried out multiple indicator dilution studies on the hepatic circulation using la beled red blood cells, albumin, and other sub stances in the dog. They concluded that the outflow patterns of these substances could best be ex plained in terms of a distribution of the transit time. Studies in humans of BBB permeability using the indicator dilution method by Hertz and Paulson (1980) revealed that the extraction of the test sub- Vol. 7, No.4, 1987 stance increased during the upslope of the venous (outflow) dilution curve. The increasing extraction can be ascribed to the heterogeneity of the cerebral circulation; the higher extraction corresponds to the longer contact with BBB and indicates a longer transit time. This finding seems to indicate the het erogeneity of the microcirculation in the human brain.
Experimental design for discrimination among the models by varying intravenous infusion time
A direct demonstration is not yet carried out for discrimination among the venous equilibrium model (model I), the tube model (model Il), and the distributed model (model III). Theoretical analysis of these three models revealed that one powerful discriminator among them is the effect of changes in the intravenous infusion time on the estimated Aa p /A.
The following design may be adopted for the dis criminatory studies. At a control infusion time (e.g., T = 0.617 min), the Aa p /A. values were cal culated to be 0.73 I for gray matter parietal and 0.407 for olfactory bulb (Table 1) (Ohno et aI., 1979 Eqs. 8, 17, 19, 33, and 35 . The predicted values calculated according to models I, II, and III need to be compared with the observed data. As we could not obtain the observed data at each infusion time, we showed the simulation lines calculated by using Ohno's data as reference point (T = 0.617 min) (Fig. 8) . Figure 8 illustrates the relationship between the (Aa pp /A)model n/(Aa p /A)model I or (Aa pp / A)model II/(Aa ppl A)model I and the infusion time of tracer at gray matter parietal and olfactory bulb calculated using Eqs. 8, 17, 19, 33, and 35, respec tively as shown in Fig. 9 . The (Aa pp /A)model II or III/ (Aa p /A)model I is smaller than 1 at T < 0.617 min, whereas it is larger than 1 at T> 0.617 min. As we could not obtain the Aa p /A values at each infusion time, the discrimination among these models has not been done. In the future, there may be a need to determine which model should be used to calculate the LCBF based on this discriminator. Analysis for the estimation of LCBF in this study is based on the tissue concentration at a single data point and is limited by actual interstudy variation of K in the same brain region under identical conditions. Re cent developments of positron emission tomog raphy imaging permit the measurement of LCBF based on multitissue concentration. This method will make it possible to analyze the multiple data points with precision and to discriminate these models.
Perspective
Indeed, the brain vasculature is a highly ramified network with cross-anastomosed and throughfare channels, like liver, lung, and kidney (Chambers and Zweifach, 1944) . Accordingly, in this study, the distributed model may be insufficient for a descrip tion of brain microcirculation. Metzger (1969) has considered the oxygen diffusion from two-and three-dimensional capillary structures in the form of square or cubic lattices, the latter intended to simulate capillary structure in the brain. An impor tant feature of this proposed model is the possibility of studying the impact of nonhomogeneous capil lary perfusion on the distribution of oxygen in the tissue. Recently, Metzger (1973 Metzger ( , 1976 applied the two-dimensional square lattice model to study on the effect of spatially nonhomogeneous oxygen consumption on oxygen distribution in the tissue. Estimation of cerebral blood flow based on this proposed space-distributed model (the ramified net work model) is in progress.
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